Viewing Study NCT01357395


Ignite Creation Date: 2025-12-24 @ 1:53 PM
Ignite Modification Date: 2025-12-27 @ 10:17 PM
Study NCT ID: NCT01357395
Status: COMPLETED
Last Update Posted: 2024-08-02
First Post: 2011-05-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer
Sponsor: Astex Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module